Search for: "Eli Lilly "
Results 1841 - 1860
of 2,131
Sort by Relevance
|
Sort by Date
13 Sep 2008, 9:58 pm
Eli Lilly & Co., 119 F.3d 1559 On June 27, 2001, relying on Eli Lilly, the district court granted Roche's motion for summary judgment of invalidity with regard to the '708 patent. [read post]
11 Sep 2008, 3:52 pm
Weinstein of the United States Federal District Court in Brooklyn decided on Friday to unseal confidential materials about Eli Lillys top-selling antipsychotic drug Zyprexa. [read post]
10 Sep 2008, 6:54 pm
here at Patent Baristas, we get all giddy when a case comes down the pike involving protein synthesis and gene cloning vectors. [read post]
9 Sep 2008, 6:28 am
Eli Lilly", with Gentry Gallery v. [read post]
8 Sep 2008, 7:52 pm
Eli Lilly & Co. back to West Virginia state courts on Tuesday, September 9. [read post]
8 Sep 2008, 1:40 pm
The ILB has had a number of entries on the Eli Lilly Zyprexa litigation, including this one from Feb. 14, 2007, quoting the NYT:A federal district judge in Brooklyn (ED NY) ruled yesterday that confidential marketing materials belonging to Eli Lilly & Company about its top-selling anti-psychotic drug Zyprexa must be returned to the company by a doctor and a lawyer who, the judge said, engaged in a scheme to leak them to the news media.and including a link… [read post]
8 Sep 2008, 3:25 am
Also, members of the House of Representatives jointly sent a letter on February 4, 2008 to an officer of the Eli Lilly Company stating that the decrease in Funding for the FDA over the past 35 years has forced a 78% reduction in food inspections and that their scientific core has been eroded to the point that they can no longer fulfill its core regulatory functions. [read post]
7 Sep 2008, 2:47 pm
However, it is good to see that at least one manufacturer, Eli Lilly was one of the first to volunteer transparency in its financial dealings with health care providers. [read post]
6 Sep 2008, 6:58 pm
Class-action suits claim that the pharmaceutical company, Eli Lilly, hid the side effects of the drug and marketed in for unapproved uses. [read post]
6 Sep 2008, 4:36 am
The plaintiffs claim that the drug giant Eli Lilly committed fraud by pricing its anti-psychotic drug Zyprexa too high and overemphasizing Zyprexa's utility. [read post]
4 Sep 2008, 6:18 pm
The nature of the allegations are that Amylin and Eli Lilly failed to adequately test Byetta before the drug was approved in 2006 and, more importantly many think, and after Byetta came out on the market and their were numerous reports of pancreatitis. [read post]
1 Sep 2008, 7:07 pm
The deaths were announced by Eli Lilly & Co. and Amylin Pharmaceuticals Inc. the companies manufacturing the drug. [read post]
29 Aug 2008, 1:25 pm
Here is IP Think Tank’s weekly selection of top intellectual property news breaking in the blogosphere and internet. [read post]
27 Aug 2008, 3:43 pm
Eli Lilly and Amylin Pharmaceuticals Inc. reported yesterday after the close of business that there were reports of four new deaths in patients taking Byetta. [read post]
21 Aug 2008, 5:03 pm
In an announcement Monday, the FDA warned patients taking Byetta, marketed by Amylin Pharmaceuticals Inc. and Eli Lilly & Co., to discontinue use if they develop symptoms of the disorder and said doctors should consider other prescription options for patients with a history of pancreas problems. [read post]
21 Aug 2008, 4:29 pm
Here is the news release from Eli Lilly, whose Elanco acquired Posilac for $300 million plus contingent consideration (whatever that is). [read post]
20 Aug 2008, 5:47 pm
Eli Lilly said Wednesday that it will pay $300 million for the rights to Posilac, Monsanto's controversial hormone to boost milk production in cows. [read post]
18 Aug 2008, 9:24 pm
.; and, The October 2007 so-called "Dear Doctor" letter about Byetta from Amylin Pharmaceuticals, Inc. and Eli Lilly and Company. [read post]
15 Aug 2008, 4:54 am
The High Court agreed with HGS' opponent, Eli Lilly, that the claimed invention in HGS' patent was not capable of industrial application (in U.S. patent parlance, the invention was found to lack utility). [read post]
12 Aug 2008, 9:31 am
In a joint letter from Merck, Pfizer, Eli Lilly, J&J, Novartis and Wyeth, the companies told FASB that that estimating the costs of continuing litigation is “highly subjective, subject to huge swings as underlying assumptions change, and unlikely to provide financial statement users with meaningful or reliable information. [read post]
